check_circleStudy Completed
Angiocardiography
Bayer Identifier:
15454
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
The safety and toleRability of UltraviSt in Patients Undergoing Cardiac CaTheterization (TRUST)
Trial purpose
This study is to collect the information of Ultravist® in the patients indicated for the coronary angiography or PCI, like rate of ADR in patients, the dose for different indications, image quality to prove Ultravist the good safety and effectivity
Key Participants Requirements
Sex
BothAge
NaN - N/ATrial summary
Enrollment Goal
17513Trial Dates
August 2010 - September 2011Phase
N/ACould I Receive a placebo
NoProducts
Ultravist (Iopromide, BAY86-4877)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many Locations, China |
Primary Outcome
- Evaluation of the safety and tolerability of Ultravist® in patients Undergoing cardiac catheterization.date_rangeTime Frame:12 monthsenhanced_encryptionYesSafety Issue:
Secondary Outcome
- Estimation of the image quality of Ultravist®date_rangeTime Frame:12 monthsenhanced_encryptionNoSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
DrugTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A